CLINICAL_TRIALS
trial_result
· 2015-08-07
Clinical Trial Update: A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial evaluating bevacizumab (Avastin) with fotemustine in patients with recurrent glioblastoma; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2015-08-07